Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Molecular and Functional Characterisation of Z-nucleic Acid-induced Signalling

Project description

Z-nucleic acids may have therapeutic use as activators of the immune system

DNA or RNA helices usually have a right-handed twist. Under conditions of stress these can also adopt a left-handed zig-zag conformation termed 'Z'. ZBP1 is a sensory molecule that recognizes RNA and DNA in the Z-form. Recognition of Z-nucleic acids by ZBP1 induces antiviral or anticancer immunity, while chronic engagement causes inflammatory pathology. The ERC-funded ZIGNALLING project aims to characterise the molecular mechanisms regulating Z-nucleic acid levels, the biophysical mechanisms of ZBP1 activation and the downstream signaling cascade after ZBP1 activation. Outcomes could lead to therapeutic strategies involving the ZBP1-mediated immune responses.

Objective

Nucleic acids are potent activators of an immune response. Z-nucleic acids are poorly defined and thermodynamically unstable conformers of double-stranded RNA/DNA helices. Recently, others and our group showed that Z-nucleic acids are recognised by the nucleic acid sensor ZBP1, thereby inducing an antiviral immune response. Activation of ZBP1 has also been shown to induce anticancer immunity and it is becoming clear that chronic engagement of ZBP1 by endogenous Z-nucleic acids causes autoinflammatory pathology. On top of that, a remarkably diverse set of cellular insults, ranging from pathogens and chemicals to genetic mutations trigger ZBP1 activation. Despite its relevance in these important (patho)physiological events, knowledge on the fundamental principles that govern Z-nucleic acid-induced ZBP1 signalling is lacking.

I here propose that ZBP1 perceives these widely different disturbances in cellular physiology by detecting the increased intracellular concentrations of Z-nucleic acids. Based on a newly developed ZBP1 activation model and using nanopore sequencing, structural biology and chemical or genetic perturbation methods, we will: (i) characterise the molecular mechanisms that regulate Z-nucleic acid levels, (ii) determine the biophysical determinants of ZBP1 activation, (iii) map the ZBP1 downstream signalling network and (iv) functionally validate our novel findings in cellular and in vivo models of ZBP1 activation.

The resulting detailed mechanistic understanding of ZBP1 function from single molecule to organism will enable us to develop future strategies for therapeutic interference with ZBP1-mediated immune responses, either negatively, to resolve autoinflammation, or positively, to promote antiviral or anticancer immunity.

Fields of science (EuroSciVoc)

This project has not yet been classified with EuroSciVoc.
Be the first one to suggest relevant scientific fields and help us improve our classification service

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC - HORIZON ERC Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2023-COG

See all projects funded under this call

Host institution

VIB VZW
Net EU contribution
€ 1 633 203,99
Address
SUZANNE TASSIERSTRAAT 1
9052 ZWIJNAARDE - GENT
Belgium
Region
Vlaams Gewest Prov. Oost-Vlaanderen Arr. Gent
Activity type
Research Organisations
Links
Total cost
€ 1 633 203,99

Beneficiaries (2)